GFACX
Price
$73.35
Change
+$0.38 (+0.52%)
Updated
Nov 19 closing price
Net Assets
327.37B
ILGRX
Price
$43.29
Change
+$0.24 (+0.56%)
Updated
Nov 19 closing price
Net Assets
7.73B
Interact to see
Advertisement

GFACX vs ILGRX

Header iconGFACX vs ILGRX Comparison
Open Charts GFACX vs ILGRXBanner chart's image
American Funds Growth Fund of Amer C
Price$73.35
Change+$0.38 (+0.52%)
VolumeN/A
Net Assets327.37B
Macquarie Large Cap Growth Fund R6
Price$43.29
Change+$0.24 (+0.56%)
VolumeN/A
Net Assets7.73B
GFACX vs ILGRX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. ILGRX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and ILGRX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 327B vs. ILGRX (7.73B). GFACX (0.00) and ILGRX (0.00) have matching dividends . GFACX was incepted earlier than ILGRX: GFACX (25 years) vs ILGRX (11 years). GFACX (1.36) is less costly to investors than ILGRX (0.63). GFACX is a more actively managed with annual turnover of: 25.00 vs. ILGRX (18.00). ILGRX (5.07) and GFACX (4.83) have marching annual gain over last year. ILGRX return over 5 years is better than : 37.33 vs. GFACX (25.13).
GFACXILGRXGFACX / ILGRX
Total Expense Ratio1.360.56243%
Annual Report Gross Expense Ratio1.360.63216%
Fund Existence25 years11 years-
Gain YTD15.0416.836220%
Front LoadN/AN/A-
Min. Initial Investment250N/A-
Min. Initial Investment IRAN/AN/A-
Net Assets327B7.73B4,229%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.835.0795%
Returns for 3 years55.6753.57104%
Returns for 5 years25.1337.3367%
Returns for 10 years70.54109.4364%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDE14.700.32
+2.23%
Coeur Mining
MBAV10.58N/A
N/A
M3 Brigade Acquisition V Corp.
JANX28.84-0.18
-0.62%
Janux Therapeutics
TLPH1.32-0.02
-1.49%
Talphera
FBIOP6.76-0.14
-2.08%
Fortress Biotech